TEC Edmonton welcomes Dr. Sharon Barker, MBA as the new Director of the TEC Edmonton Health Accelerator (TEC HA). In her new role, Sharon will be responsible for leading the next evolution of the Health Accelerator to foster the growth of Alberta biotechnology companies and strengthen the link between small and medium-sized enterprises (SMEs) and the needs of Alberta Health Services (AHS).

“The TEC Health Accelerator fulfills an important role in Alberta’s innovation ecosystem,” said Marc Leduc, Senior Provincial Director within the Research, Innovation and Analytics portfolio at Alberta Health Services. “Sharon’s experience with [Johnson and Johnson], combined with her passion and skills, will only expand the ability of our clinicians to improve the health of Albertans.”

Prior to joining TEC Edmonton, Sharon was the Medical Science Liaison with Johnson & Johnson (Janssen Pharmaceuticals Canada) where she worked with clinicians on the adoption of innovative medicines in healthcare. Sharon brings a range of experience in health and medical innovation having previously held roles in academic medical research, technology transfer and industry support, and business development with Alberta SMEs.

About TEC Edmonton
TEC Edmonton is a business accelerator helping emerging technology companies grow successfully. As a joint venture of the University of Alberta and Edmonton Economic Development Corporation, TEC Edmonton operates the Edmonton region’s largest accelerator for early-stage technology companies and manages commercialization of University of Alberta technologies.

Since 2011, TEC clients have generated $915M in revenue, raised $444M in financing and funding, invested 246M in R&D, and grown both revenue and employment by 20 per cent per year and now employ over 1,900 people in the region. TEC has assisted in the creation of 27 spin-off companies from the University of Alberta in the last six years.

In 2017, TEC Edmonton ranked #3 on the UBI Global list of World Top Business Accelerators linked to a university. For more information,  visit TECEdmonton.com.

Funding, mentorship and work space available for diagnostics companies

Company recruitment is now open for the DynaLIFE Accelerator, a new partnership between DynaLIFE, TEC Edmonton and Health City. Set to open June 2018, the program will validate cutting-edge diagnostics technologies in a real-world lab setting for approval into the health care system.

Diagnostics companies with well-developed technology can apply to the inaugural cohort and receive:

  • Clinical samples
  • Wet lab space at DynaLIFE headquarters in Edmonton
  • Mentorship from DynaLIFE, TEC Edmonton and other strategic partners
  • Funding to support the advancement of their technology

“Who knew almost half of clinical research in Alberta is focused on diagnostics technology? Those new diagnostics need a place where they can reach the finish line to real-world clinical application and commercialization,” says Jason Pincock, DynaLIFE CEO. “This accelerator will help ensure we use our research in Alberta first and build companies that develop and export these technologies to the world.”

“Alberta produces excellent technologies with commercial potential. Getting to a viable marketable product is a hurdle this accelerator will help Alberta companies achieve,” says Reg Joseph, Edmonton Health City CEO.

“This will be the third accelerator to open in partnership with TEC Edmonton over the last 18 months,” says Chris Lumb, TEC Edmonton CEO. “This demonstrates how innovation and entrepreneurship is thriving in the region and we’re thrilled to be a part of it.”

The DynaLIFE Accelerator is now accepting applications. Program and eligibility information is available here: TECEdmonton.com/DynaLIFEAccelerator

-30-

About TEC Edmonton
TEC Edmonton is a business accelerator that helps emerging technology companies grow successfully. As a joint venture of the University of Alberta and Edmonton Economic Development Corporation, TEC Edmonton operates the Edmonton region’s largest accelerator for early-stage technology companies and manages commercialization of University of Alberta technologies. TEC Edmonton delivers services in four areas: Business Development, Funding and Finance, Technology Management, and Entrepreneur Development.

Since 2011, TEC clients have generated $915M in revenue, raised $444M in financing and funding, invested 246M in R&D, and grown both revenue and employment by 20 per cent per year and now employ over 1,900 people in the region. TEC has assisted in the creation of 27 spin-off companies from the University of Alberta in the last six years.

TEC Edmonton was named the 3rd best University Business Accelerator in the world by the University Business Incubator (UBI) Global Index in 2018. For more information, visit www.www.tecedmonton.com.

About DynaLIFE

DynaLIFE is Alberta’s largest privately owned clinical laboratory. Headquartered in Edmonton, they employ over 1,200 medical, technical, and support staff throughout central and Northern Alberta.  DynaLIFE performs over 18 million publicly funded laboratory tests annually for 1.5 million Albertans in its state of the art laboratories. DynaLIFE is recognized as one of Canada’s Best Managed Companies and as one of Alberta’s Top 70 Employers. DynaLIFE Medical Labs is accredited by the College of Physicians and Surgeons of Alberta and carries international accreditation through the College of American Pathologists. DynaLIFE is a key training facility for laboratory training in Western Canada.

For more information about DynaLIFE Medical Labs, visit www.dynaLIFE.ca

About Health City

Health City is a cluster-led economic development initiative that leverages Edmonton’s tremendous health assets to position the city as a premier location for health innovation and health industry to grow. Health city operates in the space between existing and traditional health industry partners, building pathways and ease of access for innovation to become products in the marketplace. Health City’s focuses on business development, attraction and retention, navigation, stakeholder relations, advocacy, and marketing the Edmonton advantage. For more information on Health City, visit www.edmontonhealthcity.ca.

Media Contacts:
Jennifer Sheehan
Director, Communications & Marketing
TEC Edmonton
E: Jennifer.Sheehan@tecedmonton.com

T: 780-492-0707

For more information on the program, contact Craig Milne at craig.milne@tecedmonton.com.

Posted: Apr 3, 2019

A Novel Method to Produce Pitched Kefir for Reducing Cholesterol

Description Researchers at the University of Alberta and TEAGASC have jointly developed a pitched-based method to produce kefir (a fermented milk beverage) that when consumed reduces blood cholesterol levels. The......


Posted: Nov 5, 2018

Novel F-18 Beta-Hydroxybutyric Acid Radiotracers for PET Imaging

Description Researchers at the University of Alberta have synthesized novel beta-hydroxybutyric acid radiotracers for PET imaging using a 3 step radiosynthetic process. The compounds are designed to serve as radiofluorinated......


Posted: Nov 5, 2018

A Novel Method for CryoPreservation of Cells in Monolayers

Description Researchers at the University of Alberta have developed a novel method to cryopreserve cells while adhered in a monolayer configuration. This method can preserve cells on a substrate and......


Posted: Oct 30, 2018

Train-Triggered Alert System for Conditioning and Warning Wildlife

Description Researchers at the University of Alberta have developed a novel, inexpensive, and compact system to alert wildlife to approaching trains, increasing the time available to avoid a collision. Rail-caused......


Posted: Oct 19, 2018

New Topical Therapy for Melanoma

Description Dr. Afsaneh Lavasanifar and collaborators have developed a PCBCL–b-PEG-b-PCBCL (PolyGelTM) hydrogel formulation of silibinin which provides enhanced skin permeabiity and delayed release of silibinin under physiological conditions. In vitro......


Posted: Aug 2, 2018

Novel FOXM-1 inhibitors for diagnosis and treatment of cancer

Description Researchers at the University of Alberta are utilizing their new insights into the mechanism of action of FOXM-1 inhibitors to design first in class oncology drugs targeting FOXM-1 protein.......


Posted: Aug 2, 2018

Novel SERS-Based Biosensing platform for prostate cancer

Description Researchers at the University of Alberta have developed biogenic silver nanoparticles which can be used as plasmonic labels for enhanced spectroscopy applications. The nanoparticles can be modified with Raman......


Posted: Mar 29, 2018

Hand-Held Device and Computer-Implemented Steering of a Percutaneously Inserted Needle

Description Dr. Mahdi Tavakoli and his team at the University of Alberta have developed a novel hand-held device and methods to enable real-time assisted steering of percutaneously inserted needles, such as......


Posted: Mar 20, 2018

Novel Radiation-Responsive Nanoparticles for Biomedical Applications

Description Researchers at the University of Alberta in collaboration with Lakehead University have developed novel radiation-responsive block polymers for drug delivery. The nanoparticles are modified poly-L-glutamic acid (m-PGA) polymers which......


Posted: Mar 13, 2018

Flow Cytometry Sensing Using Diffracted Orders of a Grating

Description Flow cytometry is a useful tool that employed in diagnoses of various blood diseases, basic research, clinical trials or even as a “cell sorter” instrument. Currently, flow cytometry involves......


Posted: Mar 13, 2018

Off-Axis Spiral Phase Mirrors To Create Vortex Beams

Description There has been an increased interest in taking advantage of the orbital angular momentum properties of light via helical wavefronts for various applications in manufacturing, imaging, and communications. By......


Posted: Mar 6, 2018

Allyl Monomers And Polymers From Glycerol

Description In recent years, with the rapid expansion in biodiesel production, the biodiesel industry is facing the dilemma, on the one hand, of how to meet an ever-growing biofuel demand,......